Join us for the Ninth Annual HT-ADME Conference!

HT-ADME 2019 

June 20th, 2019

300 Binney Street, Building #9 
Cambridge, MA 02142


Plenary Speaker


Dennis Scott, Executive Director, Pfizer

Title TBA



Invited Speakers 


Alan Cheng, Director, Merck

Use of Artificial Intelligence/Deep Learning Computational Techniques for Prediction of ADME Endpoints


Li Di, Research Fellow, Pfizer

In Vitro and In Vivo Approaches and Applications of Tissue Kpuu


Dan Housman, Director, Deloitte

Title TBA


John Janiszewski, NIH/NCATS (National Center for Advancing Translational Sciences)

ADME-Omics: The Evolving Role of High-Throughput LC/MS in Drug Discovery


Chang Liu, Research Scientist, SCIEX

High-Throughput ESI-MS Enabled by the Acoustic Droplet Ejection to the Open-Port Probe Sampling Interface


Robin McDougall, Principal Scientist, DMPK, Alnylam Pharmaceuticals

Title TBA


Chris Nasveschuk, Vice President, Chemistry, C4 Therapeutics

Degrader Drug Space: What Rules?


Timothy Olah, Group Director at Bristol-Myers Squibb Company

Title TBA


Archana Simmons, Research Investigator II, Bristol-Myers Squibb

Title TBA


Meihua Tu, Associate Research Fellow, Pfizer

Title TBA 

Session Topics Proposed for 2019 include:

New Modalities

New Technologies and Approaches in ADME Science

Computational ADME Approaches

Tissue Targeting


Join our Linkedin Group:


Session I:  New Modalities

Session II: New Technologies and Approaches in ADME Science

Session III: Computational ADME Approaches

Sessin IV: Tissue Targeting



Click here to register for the HT-ADME conference online.

HT-ADME 2019 will take place June 20, 2019 at:


Cambridge, MA

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy